2-{4-[2-(2-Cyclopentyl-4,6-dioxo-tetrahydro-pyran-2-yl)-ethyl]-2-fluoro-phenyl}-propionitrile → 2-(4-{2-[2-Cyclopentyl-4-hydroxy-5-(6-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-ylmethyl)-6-oxo-3,6-dihydro-2H-pyran-2-yl]-ethyl}-2-fluoro-phenyl)-propionitrile
Reaction equation
[CH:1]1([C:6]2([CH2:14][CH2:15][C:16]3[CH:21]=[CH:20][C:19]([CH:22]([CH3:25])[C:23]#[N:24])=[C:18]([F:26])[CH:17]=3)[CH2:11][C:10](=[O:12])[CH2:9][C:8](=[O:13])[O:7]2)[CH2:5][CH2:4][CH2:3][CH2:2]1.C1(C2(CCC3C=CC(C4(C#N)CCC4)=C(F)C=3)CC(O)=C(CC3N=C4N=C(C)C=C(C)N4N=3)C(=O)O2)CCCC1.[CH3:67][C:68]1[CH:69]=[N:70][C:71]2[N:72]([N:74]=[C:75]([CH:77]=O)[N:76]=2)[CH:73]=1>>[CH:1]1([C:6]2([CH2:14][CH2:15][C:16]3[CH:21]=[CH:20][C:19]([CH:22]([CH3:25])[C:23]#[N:24])=[C:18]([F:26])[CH:17]=3)[CH2:11][C:10]([OH:12])=[C:9]([CH2:77][C:75]3[N:76]=[C:71]4[N:70]=[CH:69][C:68]([CH3:67])=[CH:73][N:72]4[N:74]=3)[C:8](=[O:13])[O:7]2)[CH2:5][CH2:4][CH2:3][CH2:2]1Participants
4
Reactant 3
Product 1
Procedure
The title compound was prepared analogously to example A(236) substituting 2-{4-[2-(2-cyclopentyl-4,6-dioxo-tetrahydro-pyran-2-yl)-ethyl]-2-fluoro-phenyl}-propionitrile from example A(241) in place of 1-(4-{2-[2-cyclopentyl-5-(5,7-dimethyl-[1,2,4]triazolo[1,5 -a]pyrimidin-2-ylmethyl)-4-hydroxy-6-oxo-3,6-dihydro-2H-pyran-2-yl]-ethyl}-2-fluoro-phenyl)-cyclobutanecarbonitrile and 6-methyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carbaldehyde in place of 5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carbaldehyde. 1H NMR (400 MHz, CDCl3) δ: 1.66–2.00 (m, 8H), 2.30 (s, 2H), 2.36 (s, 2H), 2.49–2.62 (m, 4H), 2.69–2.85 (m, 3H), 3.49–3.59 (m, 1H), 3.89–3.94 (m, 1H), 4.01–4.08 (m, 2H), 4.18 (s, 1H).
Sources & evidence
- ORD record
- ord-b8d89ef4c40e43d9a916c56482b67d36
- Source dataset
- uspto-grants-2006_12
- Patent number
- US07148226B2
Reaction notes
Loading…